Berberine is a Novel Mitochondrial Calcium Uniporter Inhibitor that Disrupts MCU‐EMRE Assembly
Advanced Science · 2025
DOI: 10.1002/advs.202412311 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Haixin Zhao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Nanhu Laboratory, National Center of Biomedical Analysis, 27 Tai-Ping Road, Beijing, 100039, China. Hauptthemen laut MEDLINE: Berberine, Calcium Channels, Mitochondria. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Technologies Research and Development Program, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The mitochondrial calcium uniporter (MCU) complex mediates Ca 2+ entry into mitochondria, which plays a crucial role in regulating cellular energy metabolism and apoptosis. Dysregulation of MCU is implicated in various diseases, such as neurodegenerative disorders, cardiac diseases, and cancer. Despite its importance, developing specific and clinically viable MCU inhibitors is challenging. Here, Berberine, a well‐established drug with a documented safety profile, is identified as a potent MCU inhibitor through a virtual screening of an FDA‐approved drug library. Berberine localizes within mitochondria and directly binds to the juxtamembrane loop domain of MCU. This binding disrupts the interaction of MCU with its essential regulator, EMRE, thereby inhibiting rapid Ca 2+ entry into the mitochondria. Notably, Berberine pretreatment reduces mitochondrial Ca 2+ overload and mitigates ischemia/reperfusion‐induced myocardial injury in mice. These findings establish Berberine as a potent MCU inhibitor, offering a safe therapeutic strategy for diseases associated with dysregulated mitochondrial calcium homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanhu Laboratory, National Center of Biomedical Analysis, 27 Tai-Ping Road, Beijing, 100039, China.
- State Key Laboratory of Experimental Haematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China.
- School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
- Department of Cardiology, the Sixth Medical Centre, Chinese PLA General Hospital, Beijing, 100048, China.
ORCID-Profile: Haixin Zhao, Xin Pan
Förderung
- National Natural Science Foundation of China
- Key Technologies Research and Development Program
- China Postdoctoral Science Foundation
Zitieren
APA
Zhao, H., Chen, S., Cao, N., Wu, W., Liu, G., Gao, J., Chen, J., Li, T., Lu, D., Zeng, L., Zhu, H., Zhang, W., Xia, Q., Li, T., Zhou, T., Zhang, X. M., Li, A. L., & Pan, X. (2025). Berberine is a Novel Mitochondrial Calcium Uniporter Inhibitor that Disrupts MCU‐EMRE Assembly. Advanced Science. https://doi.org/10.1002/advs.202412311
Vancouver
Zhao H, Chen S, Cao N, Wu W, Liu G, Gao J, et al. Berberine is a Novel Mitochondrial Calcium Uniporter Inhibitor that Disrupts MCU‐EMRE Assembly. Advanced Science. 2025. doi:10.1002/advs.202412311
BibTeX
@article{Zhao2025,
author = {Zhao, Haixin and Chen, Siqi and Cao, Nian and Wu, Wenjun and Liu, Guangqin and Gao, Jun and Chen, Jiayi and Li, Ting and Lu, Dingyi and Zeng, Lingmin and Zhu, Haizhen and Zhang, Weina and Xia, Qing and Li, Teng and Zhou, Tao and Zhang, Xue-Min and Li, Ai-Ling and Pan, Xin},
title = {Berberine is a Novel Mitochondrial Calcium Uniporter Inhibitor that Disrupts MCU‐EMRE Assembly},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202412311}
}
EUVIMED